✦ LIBER ✦

An Osteoporosis Clinical Pathway for the Medical Management of Patients with Low-Trauma Fracture

✍ Scribed by T. Chevalley; T. Chevalley; P. Hoffmeyer; J.-P. Bonjour; R. Rizzoli

Publisher: Springer-Verlag
Year: 2002
Tongue: English
Weight: 90 KB
Volume: 13
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s001980200053

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect on cost of medical care for p

The effect on cost of medical care for patients treated with an automated clinical audit system

✍ James C. Thomas; Ann Moore; Phyllis E. Qualls 📂 Article 📅 1983 🏛 Springer US 🌐 English ⚖ 427 KB

Granulocyte-colony stimulating factor in

Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4)¶ Protocol of a controlled clinical trial developed by consensus of an international study group¶ Part three: individual patient, complication algorithm and quality management¶

✍ B. Stinner; A. Bauhofer; W. Lorenz; M. Rothmund; U. Plaul; A. Torossian; I. Celi 📂 Article 📅 2001 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 218 KB

B cell depletion may be more effective t

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt